Source comparison
Tesamorelin Dosage Protocol: Administration Comparison
Daily Dose 2mg subcutaneous once daily Splitting dose into 1mg twice daily Fails to achieve sufficient GHRH receptor activation; GH pulse amplitude reduced by 40–60% Reconstitution Volume 1mL bacteriostatic water per 2mg vial Using sterile saline or distilled
This comparison does not assign a generated winner or score.
- Daily Dose
- 2mg subcutaneous once daily
- Splitting dose into 1mg twice daily
- Fails to achieve sufficient GHRH receptor activation; GH pulse amplitude reduced by 40–60%
- Reconstitution Volume
- 1mL bacteriostatic water per 2mg vial
- Using sterile saline or distilled water
- Bacterial growth in multi-dose vials; peptide must be discarded after 24 hours
- Injection Timing
- Evening, 1–2 hours before bed, 2+ hours post-meal
- Injecting immediately after meals or in the morning
- Blunted GH response due to elevated insulin; misses circadian GH peak during sleep
- Storage Temperature
- 2–8°C refrigerated after reconstitution
- Storing at room temperature or in fridge door
- Peptide degrades 60–80% within 48 hours at 20–25°C; complete loss of potency above 30°C
- Use Timeline
- Discard 28 days after reconstitution
- Continuing use beyond 28 days
- Peptide potency declines exponentially; benzyl alcohol preservative effectiveness ends
- Bottom Line
- Precision at every step. Reconstitution, timing, and storage. Determines whether tesamorelin produces clinical GH elevation or expensive placebo injections
- Protocol deviations don't cause dramatic side effects; they silently eliminate efficacy while the patient continues injecting inert solution